Yang Jiarui, Zhu Shuguang, Yong Juanjuan, Xia Long, Qian Xiangjun, Yang Jiawei, Hu Xueqiao, Li Yuxuan, Wang Chusi, Peng Wenguang, Zhang Lei, Deng Meihai, Pan Weidong
Department of Biliary-Pancreatic Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Front Oncol. 2021 Mar 4;11:616976. doi: 10.3389/fonc.2021.616976. eCollection 2021.
Microvascular invasion (MVI) is highly associated with poor prognosis in patients with liver cancer. Predicting MVI before surgery is helpful for surgeons to better make surgical plan. In this study, we aim at establishing a nomogram to preoperatively predict the occurrence of microvascular invasion in liver cancer.
A total of 405 patients with postoperative pathological reports who underwent curative hepatocellular carcinoma resection in the Third Affiliated Hospital of Sun Yat-sen University from 2013 to 2015 were collected in this study. Among these patients, 290 were randomly assigned to the development group while others were assigned to the validation group. The MVI predictive factors were selected by Lasso regression analysis. Nomogram was established to preoperatively predict the MVI risk in HCC based on these predictive factors. The discrimination, calibration, and effectiveness of nomogram were evaluated by internal validation.
Lasso regression analysis revealed that discomfort of right upper abdomen, vascular invasion, lymph node metastases, unclear tumor boundary, tumor necrosis, tumor size, higher alkaline phosphatase were predictive MVI factors in HCC. The nomogram was established with the value of AUROC 0.757 (0.716-0.809) and 0.768 (0.703-0.814) in the development and the validation groups. Well-fitted calibration was in both development and validation groups. Decision curve analysis confirmed that the predictive model provided more benefit than treat all or none patients. The predictive model demonstrated sensitivity of 58.7%, specificity of 80.7% at the cut-off value of 0.312.
Nomogram was established for predicting preoperative risk of MVI in HCC. Better treatment plans can be formulated according to the predicted results.
微血管侵犯(MVI)与肝癌患者的不良预后高度相关。术前预测MVI有助于外科医生更好地制定手术方案。在本研究中,我们旨在建立一种列线图,用于术前预测肝癌微血管侵犯的发生情况。
本研究收集了2013年至2015年在中山大学附属第三医院接受根治性肝细胞癌切除术且有术后病理报告的405例患者。其中,290例被随机分配至开发组,其余患者被分配至验证组。通过Lasso回归分析选择MVI预测因素。基于这些预测因素建立列线图,以术前预测肝癌患者的MVI风险。通过内部验证评估列线图的区分度、校准度和有效性。
Lasso回归分析显示,右上腹不适、血管侵犯、淋巴结转移、肿瘤边界不清、肿瘤坏死、肿瘤大小、碱性磷酸酶升高是肝癌患者MVI的预测因素。开发组和验证组列线图的曲线下面积(AUROC)值分别为0.757(0.716 - 0.809)和0.768(0.703 - 0.814)。开发组和验证组的校准度均良好。决策曲线分析证实,该预测模型比全部治疗或不治疗患者提供了更多益处。在截断值为0.312时,预测模型的敏感性为58.7%,特异性为80.7%。
建立了用于预测肝癌患者术前MVI风险的列线图。可根据预测结果制定更好的治疗方案。